The Board of Directors has recommended 0.15% Cash Dividend only for General Shareholders excluding Sponsors and Directors for the year ended June 30, 2026. The quantities of securities held by the sponsors and directors: 27,957,751 shares. The amount payable to the general shareholders is Tk. 977,624.715. Date of AGM: 28th December, 2026, Time: 10:00 AM, Venue: Hybrid System. Record Date: 22nd November, 2026. The Company has also reported EPS of Tk. 0.42, NAV per share of Tk. 16.81 and NOCFPS of Tk. 0.15 for the year ended June 30, 2026 as against EPS of Tk. 0.72, NAV per share of Tk. 16.43 and NOCFPS of Tk. 1.23 for the year ended June 30, 2025.

There will be no price limit on the trading of the shares of the Company today (27.10.2026) following its corporate declaration.

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2026 at 3:00 PM to consider, among others, annual audited financial statements of the Company for the year ended June 30, 2026.

(Q3 Un-audited): EPS was Tk. 0.09 for January-March 2026 as against Tk. 0.19 for January-March 2025; EPS was Tk. 0.33 for July 2025-March 2026 as against Tk. 0.53 for July 2024-March 2025. NOCFPS was Tk. 0.12 for July 2025-March 2026 as against Tk. 0.89 for July 2024-March 2025. NAV per share was Tk. 16.72 as on March 31, 2026 and Tk. 16.43 as on March 31, 2025.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2026 at 3:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.

The Company did not submit the Dividend Distribution Compliance Report as per clause no. 6 of BSEC Directive No. BSEC/CMRRCD/2021-386/03 dated January 14, 2021 and Regulation 29 of the Dhaka Stock Exchange (Listing) Regulations, 2015 in connection with disbursement of the declared dividend for the year ended June 30, 2025. However, Dhaka Stock Exchange PLC. (DSE) has issued a query letter to the company in this regard.

(Q2 Un-audited): EPS was Tk. 0.09 for October-December 2025 as against Tk. 0.18 for October-December 2024; EPS was Tk. 0.24 for July-December 2025 as against Tk. 0.34 for July-December 2024. NOCFPS was Tk. 0.16 for July-December 2025 as against Tk. 0.66 for July-December 2024. NAV per share was Tk. 16.64 as on December 31, 2025 and Tk. 16.43 as on June 30, 2025.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2026 at 3:00 PM to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended December 31, 2025.

The auditor of the company has given the Emphasis of Matters paragraph in the audited financial statements of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/Advent%20Pharma2025.pdf

Alpha Credit Rating PLC. has assigned Surveillance rating of the Company as "A-" in the long term and "ST-3" in the short term along with Stable outlook based on audited financial statements up to 30 June, 2025 and relevant qualitative information till December 08, 2025.